What is the percentage of diamide sales that are currently in combinations 
 than the generic market itself.
Mark Connelly -- Stephens -- Analyst
Super. Thank you.
Operator
And the next question will be from Vincent Andrews of Morgan Stanley. Please go ahead.
Vincent Andrews -- Morgan Stanley -- Analyst
Thank you very much. Good morning, everyone. Maybe just to get back to the Asia or India discussion a little bit, just wondering, sort of as you look at the growth plan there, how much of it is just going to come down to continuing to penetrate your existing molecules versus is there going to be -- and I don't want to front run your R&D day either but, is there going to be a story about some new products that are going to have good applicability there? Or is there also, maybe an M&A role up opportunity in the region that might make sense or is it a bit of all three? Thank you.
Mark A. Douglas -- President and Chief Executive Officer
Yeah, it's a bit of the first two, not necessarily the last one I think, Vincent. Yes, we do have geographic expansion and also crop expansion in India. Those fruit and vegetable markets themselves are highly fragmented. So, we've talked before, as I said about the registration profile and how we're increasing that. India plays a significant role in getting our products onto more crops in different parts of the country. Certainly, I'm not going to go into all the details of the pipeline. I'm going to do that in two weeks. But yes, the pipeline has applicability in India. I also think there are some agronomic changes going on that we see that are benefiting us. I'll give you an example. In Brazil, the sugarcane business is highly mechanized. In India, it is not, yet there are labor shortages. So in Brazil, where we are a leading provider of herbicides for the sugarcane market. We're now building a pre-emergent herbicide business in sugarcane in India, which is a brand new market. It used to be manually controlled and now they're using -- starting to use pre-emergent herbicide. That's a great example of the market that didn't exist a few years ago that is now growing rapidly and we can transfer technology and knowhow from Brazil to India. And in fact, in the past -- in the past few years, we have had India sugarcane growers go to Brazil to see the difference between the agronomic practices. That's all investment that allows us to continue to expand our market share and our market growth.
Operator
Thank you. And the next question will be from John Roberts with UBS. Please go ahead.
John Roberts -- UBS Research -- Analyst
Thank you. Maybe just to give us a little bit of preview of your technology day. It sounds like you're having good success in the combinations of the diamides, maybe you could comment what percent of that diamide sales are currently in combinations and what would you think that will be a few years from now?
Mark A. Douglas -- President and Chief Executive Officer
Yeah, John, we don't actually break out what are straight products versus what are formulated products, but certainly we are having success. We talk about the Elevest we just launched. We've got a couple of others coming this year. I don't think it will ever make up the vast majority of ourselves into this space. But certainly as we fragment the market and some of the partners that we're working with, as they look at the sales, they are also likely to have a mixture of products that they will do. So it may not be that FMC has those mixture partners, all those formulated products, but our partner companies will have. So you will see a growth in that type of -- part of the market but we might not necessarily have that ourselves. We will have some, obviously, because we're working on that but I think the general market itself will continue to fragment with more formulated type products.
John Roberts -- UBS Research -- Analyst
Thank you.
Operator
And the next question is from Frank Mitsch with Fermium Research. Please go ahead.
Frank Mitsch -- Fermium Research -- Analyst
Yeah, good morning folks and an impressive results here in the third quarter. So as I look at your results for this year and the g
 than the generic market itself.
Mark Connelly -- Stephens -- Analyst
Super. Thank you.
Operator
And the next question will be from Vincent Andrews of Morgan Stanley. Please go ahead.
Vincent Andrews -- Morgan Stanley -- Analyst
Thank you very much. Good morning, everyone. Maybe just to get back to the Asia or India discussion a little bit, just wondering, sort of as you look at the growth plan there, how much of it is just going to come down to continuing to penetrate your existing molecules versus is there going to be -- and I don't want to front run your R&D day either but, is there going to be a story about some new products that are going to have good applicability there? Or is there also, maybe an M&A role up opportunity in the region that might make sense or is it a bit of all three? Thank you.
Mark A. Douglas -- President and Chief Executive Officer
 Yeah, it's a bit of the first two, not necessarily the last one I think, Vincent. Yes, we do have geographic expansion and also crop expansion in India. Those fruit and vegetable markets themselves are highly fragmented. So, we've talked before, as I said about the registration profile and how we're increasing that. India plays a significant role in getting our products onto more crops in different parts of the country. Certainly, I'm not going to go into all the details of the pipeline. I'm going to do that in two weeks. But yes, the pipeline has applicability in India. I also think there are some agronomic changes going on that we see that are benefiting us. I'll give you an example. In Brazil, the sugarcane business is highly mechanized. In India, it is not, yet there are labor shortages. So in Brazil, where we are a leading provider of herbicides for the sugarcane market. We're now building a pre-emergent herbicide business in sugarcane in India, which is a brand new market. It used to be manually controlled and now they're using -- starting to use pre-emergent herbicide. That's a great example of the market that didn't exist a few years ago that is now growing rapidly and we can transfer technology and knowhow from Brazil to India. And in fact, in the past -- in the past few years, we have had India sugarcane growers go to Brazil to see the difference between the agronomic practices. That's all investment that allows us to continue to expand our market share and our market growth.
Operator
Thank you. And the next question will be from John Roberts with UBS. Please go ahead.
John Roberts -- UBS Research -- Analyst
Thank you. Maybe just to give us a little bit of preview of your technology day. It sounds like you're having good success in the combinations of the diamides, maybe you could comment what percent of that diamide sales are currently in combinations and what would you think that will be a few years from now?
Mark A. Douglas -- President and Chief Executive Officer
 Yeah, John, we don't actually break out what are straight products versus what are formulated products, but certainly we are having success. We talk about the Elevest we just launched. We've got a couple of others coming this year. I don't think it will ever make up the vast majority of ourselves into this space. But certainly as we fragment the market and some of the partners that we're working with, as they look at the sales, they are also likely to have a mixture of products that they will do. So it may not be that FMC has those mixture partners, all those formulated products, but our partner companies will have. So you will see a growth in that type of -- part of the market but we might not necessarily have that ourselves. We will have some, obviously, because we're working on that but I think the general market itself will continue to fragment with more formulated type products.
John Roberts -- UBS Research -- Analyst
Thank you.
Operator
And the next question is from Frank Mitsch with Fermium Research. Please go ahead.
Frank Mitsch -- Fermium Research -- Analyst
Yeah, good morning folks and an impressive results here in the third quarter. So as I look at your results for this year and the g